Central Lung Tumors Eligible for Stereotactic Ablative Radiotherapy (SABR) Trials: Analysis of a Cohort Treated Using MR-Guided SABR

被引：0
|
作者：
Giraud, N. [1 ]
Schneiders, F. L. [1 ]
Palacios, M. A. [1 ]
de Koste, J. R. van Sornsen [1 ]
Sesan, S. [1 ]
机构：
[1] Amsterdam UMC, Amsterdam, Netherlands
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2041
引用
收藏
页码：E20 / E20
页数：1
相关论文
共 50 条
  • [41] Stereotactic Ablative Radiotherapy (SABR) for Prostate Cancer - an Analysis of 500 Consecutive Patients Treated at a Single Institution
    Miszczyk, L.
    Namysl-Kaletka, A. J.
    Napieralska, A.
    Kraszkiewicz, M.
    Miszczyk, M.
    Wozniak, G.
    Stapor-Fudzinska, M.
    Glowacki, G.
    Tukiendorf, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E295 - E295
  • [42] Stereotactic Ablative Radiotherapy (SABR) For Oligometastases: Risk Stratification Using Positional Uncertainty
    Zhang, T.
    Clark, H.
    Thomas, S.
    Olson, R. A.
    Ma, R.
    Schellenberg, D.
    Tyldesley, S.
    Palma, D. A.
    Liu, M. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E180 - E181
  • [43] Influence of Dose and Fractionation on Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR)
    Ross, J. B.
    Ross, J. B.
    Merriott, D. J.
    Alhumaid, S.
    Schueler, E.
    Ko, R. B.
    Bush, K.
    Maxim, P. G.
    Gensheimer, M. F.
    Loo, B. W., Jr.
    Diehn, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E527 - E528
  • [44] Clinical Characteristics Matrix of Lung Tumor Under Stereotactic Ablative Body Radiotherapy (SABR)
    Li, K.
    Jung, E.
    Wu, B.
    Mousli, A.
    Aoki, S.
    Newton, J.
    Able, A.
    Cornell, D.
    Lee, N.
    Lo, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2333 - S2333
  • [45] Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment
    Geng-Cahuayme, Abraham Andre Arturo
    Peregrin-Pastor, Blanca
    Ramos-Albiac, Monica
    Recalde-Vizcay, Enar
    Parada-Zuluaga, Juan Sebastian
    de Sagredo, Jordi Giralt-Lopez
    Maldonado-Pijoan, Xavier
    Giraldo-Marin, Alexandra
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (12): : 3246 - 3251
  • [46] Two Centre Feasibility study of single fraction lung stereotactic ablative radiotherapy (SABR)
    Jani, Z.
    Chiu, M.
    Petkar, S.
    Blower, A.
    Grimes, H.
    Lalli, N.
    Akasha, R.
    Johnson, D.
    Masinghe, S.
    Kumar, G.
    Moinuddin, S. A. A.
    Dubash, S.
    Peedell, C.
    Wilson, J.
    Aynsley, E.
    Hiley, C.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S420 - S421
  • [47] Factors Affecting Use of Stereotactic Ablative Radiotherapy (SABR) in Patients with Inoperable Lung Cancer
    Syed, Mohshin
    Jayasekera, Geeshath
    Rushd, Farwah
    LUNG CANCER, 2025, 200
  • [48] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) FOR OLIGOMETASTASES: RISK STRATIFICATION USING POSITIONAL UNCERTAINTY
    Zhang, Tina
    Clark, Haley
    Thomas, Steven
    Olson, Robert
    Ma, Roy
    Schellenberg, Devin
    Palma, David
    Liu, Mitchell
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S85 - S86
  • [49] Splenic Irradiation and Late Volume Changes Following Stereotactic Ablative Radiotherapy (SABR) for Adrenal Tumors
    Giraud, N.
    Schneiders, F. L.
    de Koste, J. R. van Sornsen
    Palacios, M. A.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E385 - E386
  • [50] Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors
    Padgett, Kyle R.
    Simpson, Garrett N.
    Llorente, Ricardo
    Samuels, Michael A.
    Dogan, Nesrin
    CUREUS, 2018, 10 (04):
12345